Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus

Objective. To assess change of annexin-5 antibodies (AA5) level and AA5 influence on gestation outcome in pregnant women with systemic lupus erythematosus (SLE).Material and methods. 15 pregnant women with SLE who fulfilled 1997 ACR criteria (4 of them with concomitant antiphospholipid syndrome – AP...

Full description

Saved in:
Bibliographic Details
Main Authors: Z. S. Alekberova, N. M. Kosheleva, E. N. Alexandrova, S. I. Husmieva, A. A. Novikov, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2016-05-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2184
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839568401989632000
author Z. S. Alekberova
N. M. Kosheleva
E. N. Alexandrova
S. I. Husmieva
A. A. Novikov
E. L. Nasonov
author_facet Z. S. Alekberova
N. M. Kosheleva
E. N. Alexandrova
S. I. Husmieva
A. A. Novikov
E. L. Nasonov
author_sort Z. S. Alekberova
collection DOAJ
description Objective. To assess change of annexin-5 antibodies (AA5) level and AA5 influence on gestation outcome in pregnant women with systemic lupus erythematosus (SLE).Material and methods. 15 pregnant women with SLE who fulfilled 1997 ACR criteria (4 of them with concomitant antiphospholipid syndrome – APS) were included. Median age of pts was 28,0 (23- 33) years, median SLE duration – 4,0 (3-9) years. SLEDAI activity score at the beginning of gestation was 2 (2-11). All but one pts received metypred from 2 to 20 mg/day. The women were examined in every trimester of gestation. AA5 and anticardiolipine antibodies (ACLA) were evaluated with immunoenzyme assay.Results. AA5 elevation was revealed in 7 women (group 1): 6 of them were only IgG AA5 positive, 1 had both IgG and IgM AA5. Isolated IgM AA5 elevation was absent. 4 pts had borderline IgG AA5 values (from 5,3 to 7,4 U/ml). 3 pts had respectively 9,6, 12,1 and 168,5 U/ml. The last pt was also positive for IgM AA5 (till 14,4 U/ml). AA5 elevation was more frequent and more prominent during the II trimester of gestation. 8 pts with SLE (group 2) did not have AA5 elevation. 11 from 15 gestations ended with birth of viable baby, the rest 4 had unfavorable outcome. Median terms of delivery did not differ in both groups and came to 36 weeks. 3 pts with normal AA5 and 1 pt with elevated AA5 had gestation lost. 3 from these 4 pts were ACLA positive and APS was earlier diagnosed in 2 from them.Conclusion. Almost half of pregnant women with SLE (7 from 15) had AA5 elevation mainly during the II trimester of gestation. Unfavorable gestation outcomes were not associated with AA5 elevation. Possibly low levels of AA5 positivity and small sample size could influence the results.
format Article
id doaj-art-b10ea13e69ce4a9eb947f032c4df7aea
institution Matheson Library
issn 1995-4484
1995-4492
language Russian
publishDate 2016-05-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-b10ea13e69ce4a9eb947f032c4df7aea2025-08-04T17:03:56ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922016-05-01454313410.14412/1995-4484-2007-31-342061Antibodies to annexin-5 in pregnant women with systemic lupus erythematosusZ. S. Alekberova0N. M. Kosheleva1E. N. Alexandrova2S. I. Husmieva3A. A. Novikov4E. L. Nasonov5ГУ Институт ревматологии РАМН, МоскваГУ Институт ревматологии РАМН, МоскваГУ Институт ревматологии РАМН, МоскваГУ Институт ревматологии РАМН, МоскваГУ Институт ревматологии РАМН, МоскваГУ Институт ревматологии РАМН, МоскваObjective. To assess change of annexin-5 antibodies (AA5) level and AA5 influence on gestation outcome in pregnant women with systemic lupus erythematosus (SLE).Material and methods. 15 pregnant women with SLE who fulfilled 1997 ACR criteria (4 of them with concomitant antiphospholipid syndrome – APS) were included. Median age of pts was 28,0 (23- 33) years, median SLE duration – 4,0 (3-9) years. SLEDAI activity score at the beginning of gestation was 2 (2-11). All but one pts received metypred from 2 to 20 mg/day. The women were examined in every trimester of gestation. AA5 and anticardiolipine antibodies (ACLA) were evaluated with immunoenzyme assay.Results. AA5 elevation was revealed in 7 women (group 1): 6 of them were only IgG AA5 positive, 1 had both IgG and IgM AA5. Isolated IgM AA5 elevation was absent. 4 pts had borderline IgG AA5 values (from 5,3 to 7,4 U/ml). 3 pts had respectively 9,6, 12,1 and 168,5 U/ml. The last pt was also positive for IgM AA5 (till 14,4 U/ml). AA5 elevation was more frequent and more prominent during the II trimester of gestation. 8 pts with SLE (group 2) did not have AA5 elevation. 11 from 15 gestations ended with birth of viable baby, the rest 4 had unfavorable outcome. Median terms of delivery did not differ in both groups and came to 36 weeks. 3 pts with normal AA5 and 1 pt with elevated AA5 had gestation lost. 3 from these 4 pts were ACLA positive and APS was earlier diagnosed in 2 from them.Conclusion. Almost half of pregnant women with SLE (7 from 15) had AA5 elevation mainly during the II trimester of gestation. Unfavorable gestation outcomes were not associated with AA5 elevation. Possibly low levels of AA5 positivity and small sample size could influence the results.https://rsp.mediar-press.net/rsp/article/view/2184systemic lupus erythematosusgestationannexin-5 antibodies
spellingShingle Z. S. Alekberova
N. M. Kosheleva
E. N. Alexandrova
S. I. Husmieva
A. A. Novikov
E. L. Nasonov
Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus
Научно-практическая ревматология
systemic lupus erythematosus
gestation
annexin-5 antibodies
title Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus
title_full Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus
title_fullStr Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus
title_full_unstemmed Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus
title_short Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus
title_sort antibodies to annexin 5 in pregnant women with systemic lupus erythematosus
topic systemic lupus erythematosus
gestation
annexin-5 antibodies
url https://rsp.mediar-press.net/rsp/article/view/2184
work_keys_str_mv AT zsalekberova antibodiestoannexin5inpregnantwomenwithsystemiclupuserythematosus
AT nmkosheleva antibodiestoannexin5inpregnantwomenwithsystemiclupuserythematosus
AT enalexandrova antibodiestoannexin5inpregnantwomenwithsystemiclupuserythematosus
AT sihusmieva antibodiestoannexin5inpregnantwomenwithsystemiclupuserythematosus
AT aanovikov antibodiestoannexin5inpregnantwomenwithsystemiclupuserythematosus
AT elnasonov antibodiestoannexin5inpregnantwomenwithsystemiclupuserythematosus